Alimera Sciences
Kelly Frade is currently a Senior Medical Sciences Liaison at ANI Pharmaceuticals, Inc. and has been in similar roles at Alimera Sciences since October 2018, where contributions have focused on ophthalmology-related conditions such as Diabetic Macular Edema, Non-infectious Uveitis, Age-related Macular Degeneration, Dry Eye Disease, and Glaucoma. Notable awards include Best MSL Europe 2022 and Best MSL Team of the Year in 2021 from Alimera Sciences. Kelly's experience also includes research fellow positions in oxidative stress and diabetes research, alongside various roles as a pharmacist. An Integrated Master's Degree in Pharmaceutical Sciences was earned from the Instituto Superior de Ciências da Saúde Egas Moniz, complemented by specialized training in protein biochemistry from UiT- The Arctic University of Norway.
This person is not in any offices
Alimera Sciences
1 followers
Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...